🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hypothesis: Modulation of central nervous sympathetic activation by adminis...
Status
Completed
Location
Evangelismos General Hospital
Start Date
2012-08
Trial ID
NCT01791699
Treatments Being Tested
This study is to demonstrate the superiority of combination of eprosartan/H...
Status
Completed
Location
Site 26
Start Date
2004-10
Trial ID
NCT00160160
Treatments Being Tested
We will study obese hypertensive subjects in a randomized, crossover study ...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2022-05-20
Trial ID
NCT05312892
Treatments Being Tested
Obesity is a major risk factor for the development of hypertension. Based o...
Status
Unknown
Location
BakerIDI Heart and Diabetes Institute
Start Date
2012-01
Trial ID
NCT01360710
Treatments Being Tested
The purpose of this study is to determine whether moxonidine is effective i...
Status
Completed
Location
Alfred & Baker Medical Unit
Start Date
2011-04
Trial ID
NCT01094769
Treatments Being Tested
This study is designed to investigate whether sympathoinhibition with moxon...
Status
Unknown
Location
Dobney Hypertension Centre
Start Date
2015-06-24
Trial ID
NCT04474899
Treatments Being Tested
Postural tachycardia syndrome (POTS) is a relatively common condition affec...
Status
Active Not Recruiting
Location
Vanderbilt University Medical Center
Start Date
2021-08-31
Trial ID
NCT04140721
Treatments Being Tested
Investigating the perioperative effect of moxonidine. In a randomized doubl...
Status
Terminated
Location
University hospital
Start Date
2002-11
Trial ID
NCT00244504
Treatments Being Tested
Polycystic ovary syndrome affects a striking 9-18% of Australian reproducti...
Status
Completed
Location
Heart Centre, Alfred Hospital
Start Date
2012-05
Trial ID
NCT01504321
Treatments Being Tested
Treatment with monotherapy of moxonidine 0.6 mg daily in treatment-naïve su...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-11
Trial ID
NCT05147753
Treatments Being Tested